Search Results

January 09, 2019  

Cancer Specialist Preps Hedge Fund

Arcus Ventures, a private equity investor specializing in oncology-related businesses, is starting a hedge fund.The New York firm aims to begin trading before the end of the first half with about $50 million. The yet-to-be-named vehicle would take long and short positions in companies that develop cancer treatments including drugs, drug-delivery systems, diagnostic tests and medical devices.Arcus, founded in 2007, is led by James Dougherty and...

This article is free to subscribers of Hedge Fund Alert. If you are a subscriber, please sign in.

If you are not a subscriber, please complete the form below to purchase the article for $19.95.
First Name *
Last Name *
E-mail *
Card Number *
Expiration *
Card Code *
Address *
City *
State/Province *
Zip/Postal Code *

Purchase Article